M. Talamonti, “Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study”, Acta Derm Venereol, vol. 101, no. 3, p. adv00422, Mar. 2021.